Dr. Berdeja on Maintenance Therapy in Multiple Myeloma

(1:25)

Dr. Berdeja Discusses Next Steps With bb2121 in Multiple Myeloma

(1:36)

Dr. Berdeja on Updated CARTITUDE-1 Results With JNJ-4258 in Multiple Myeloma

(59)

Dr. Berdeja on Next Steps With JNJ-4528 in Relapsed/Refractory Myeloma

(1:20)

Dr. Berdeja on FDA Approval of Frontline Daratumumab Plus VMP in Multiple Myeloma

(38)

Dr. Berdeja Discusses the Future of Treatment for Myeloma

(1:6)

Dr. Berdeja Discusses Response to CAR T-Cell Therapy bb2121

(1:53)

Dr. Berdeja Discusses Anticipated Research in Multiple Myeloma

(1:32)

Mujer rompe cristales de auto de su esposo al cacharlo engañándola con una de sus alumnas

(1:34)

Revelan video previo al brutal accidente que dejó ocho muertos en La Línea | El Tiempo

(1:13)

El GRAN SECRETO del Golfo de México: la Isla Bermeja | Alfredo Jalife

(15:42)

We Don't Know What To Do - Stephen J. Bramer

(29:37)

“The best decision I’ve made!” Radiologist Dr. Perez Perez's vRad Experience After Fellowship

(2:42)

What is Multiple Myeloma?

(2:)

Todo empezó con una riña dentro del Cereso en Ciudad Juárez. Habla Mejía Berdeja

(2:29)

The future in multiple myeloma: BiTE immunotherapy, CAR-T, and immune checkpoint inhibitors

(21:41)

FAQs on Newly Diagnosed Multiple Myeloma

(55:43)

Know Your Myeloma Immunotherapy: Antibody Drug Conjugates with Dr. Jesus Berdeja

(57:55)

Dr. Berdeja on Dosing JNJ-4528 in Relapsed/Refractory Multiple Myeloma

(1:29)

Dr. Berdeja on Treatment of Patients With Newly Diagnosed Myeloma

(1:58)

New Indication for Sarclisa in Myeloma: What HCPs Need to Know – Dr. Jesus Berdeja

(2:56)

Copy of Dr. Berdeja Discusses Anticipated Research in Multiple Myeloma

(26)

Dr. Berdeja Discusses Results for bb2121 in Multiple Myeloma

(3:55)

Dr. Berdeja on Updated Data With bb21217 in Multiple Myeloma

(1:29)

CAR T-CELL Therapy in Multiple Myeloma, When \u0026 How Effective - Dr. Jesus Berdeja(Sep 30-Oct 1, 2022)

(22:41)

Multiple Myeloma, how to sequence new therapies - Dr. Jesus Berdeja (Sep 30-Oct 1, 2022)

(25:31)

Blenrep (belantamab mafadotin) for multiple myeloma — Dr. Jesus Berdeja | MCRT Webcast August 22

(11:39)

Jesus Berdeja, MD, describes how BCMA targeting differs from other CAR-T cell therapies

(1:7)